2016 update of the EULAR recommendations for the management of early arthritis

Bernard Combe, Robert Landewe, Claire I. Daien, Charlotte Hua, Daniel Aletaha, Jose María Álvaro-Gracia, Margôt Bakkers, Nina Brodin, Gerd R. Burmester, Catalin Codreanu, Richard Conway, Maxime Dougados, Paul Emery, Gianfranco Ferraccioli, Joao Fonseca, Karim Raza, Lucía Silva-Fernández, Josef S. Smolen, Diana Skingle, Zoltan SzekaneczTore K. Kvien, Annette Van Der Helm-Van Mil, Ronald Van Vollenhoven

Research output: Contribution to journalArticle

142 Citations (Scopus)

Abstract

Objectives Since the 2007 recommendations for the management of early arthritis have been presented, considerable research has been published in the field of early arthritis, mandating an update of the 2007 European League Against Rheumatism (EULAR) recommendations for management of early arthritis. Methods In accordance with the 2014 EULAR Standardised Operating Procedures, the expert committee pursued an approach that was based on evidence in the literature and on expert opinion. The committee involved 20 rheumatologists, 2 patients and 1 healthcare professional representing 12 European countries. The group defined the focus of the expert committee and target population, formulated a definition of a management' and selected the research questions. A systematic literature research (SLR) was performed by two fellows with the help of a skilled librarian. A set of draft recommendations was proposed on the basis of the research questions and the results of the SLR. For each recommendation, the categories of evidence were identified, the strength of recommendations was derived and the level of agreement was determined through a voting process. Results The updated recommendations comprise 3 overarching principles and 12 recommendations for managing early arthritis. The selected statements involve the recognition of arthritis, referral, diagnosis, prognostication, treatment (information, education, pharmacological and non-pharmacological interventions), monitoring and strategy. Eighteen items were identified as relevant for future research. Conclusions These recommendations provide rheumatologists, general practitioners, healthcare professionals, patients and other stakeholders with an updated EULAR consensus on the entire management of early arthritis.

Original languageEnglish
Article numberannrheumdis-2016-210602
Pages (from-to)948-959
Number of pages12
JournalAnnals of the rheumatic diseases
Volume76
Issue number6
DOIs
Publication statusPublished - Jun 1 2017

Keywords

  • DMARDs (synthetic)
  • Early Rheumatoid Arthritis
  • Patient perspective
  • Rheumatoid Arthritis
  • Treatment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of '2016 update of the EULAR recommendations for the management of early arthritis'. Together they form a unique fingerprint.

  • Cite this

    Combe, B., Landewe, R., Daien, C. I., Hua, C., Aletaha, D., Álvaro-Gracia, J. M., Bakkers, M., Brodin, N., Burmester, G. R., Codreanu, C., Conway, R., Dougados, M., Emery, P., Ferraccioli, G., Fonseca, J., Raza, K., Silva-Fernández, L., Smolen, J. S., Skingle, D., ... Van Vollenhoven, R. (2017). 2016 update of the EULAR recommendations for the management of early arthritis. Annals of the rheumatic diseases, 76(6), 948-959. [annrheumdis-2016-210602]. https://doi.org/10.1136/annrheumdis-2016-210602